Regarding the Suit: "We believe that our 2016 s
Post# of 11802
![](/assets/46931549/no_avatar_available_thumb.jpg)
"We believe that our 2016 suit against J&J will be settled sooner rather than later. Nonetheless, the company is prepared to litigate this case to its conclusion, and if necessary bring into the suit the acquirer of J&J’s
diabetes divisions. Further, in January 2016 the US Supreme Court ruled that the Doctrine of Laches, a defense used by many Defendants in patent infringement suits could no longer be used. This ruling further deprived J&J of
one of its most important (time wasting) defenses against the company’s current patent infringement claims."
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)